FOLD AMICUS THERAPEUTICS INC

Ownership history in Prosight Management, LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which Prosight Management, LP reported a position in AMICUS THERAPEUTICS INC (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.86% (2025 Q2)
Avg. % of fund
3.5%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 1,150,000 -559,533 -32.7% 3.38% $16.4M $14.24
2025 Q3 REDUCED 1,709,533 -1,770,511 -50.9% 3.14% $13.5M $7.88
2025 Q2 ADDED 3,480,044 +2,100,661 +152.3% 4.86% $19.9M $5.73
2025 Q1 ADDED 1,379,383 +459,383 +49.9% 3.70% $11.3M $8.16
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FOLD price (monthly, adj. close)
← Back to Prosight Management, LP Holdings